
|Videos|September 9, 2021
Exploring new biological treatments in posterior uveitis
Author(s)Modern Retina Staff Reports
Quan Dong Nguyen, MD, MSc, FARVO, FASRS, speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.
Advertisement
Quan Dong Nguyen, MD, MSc, FARVO, FASRS, director of the Uveitis and Ocular Inflammation Service, Byers Eye Institute, Stanford University School of Medicine, speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
The Retina TL;DR: Advancing sustained VEGF suppression with EYP-1901 with Jay S. Duker, MD
2
Increasing the knowledge base of GA is key to individualizing patient therapy
3
Study finds retinal progenitor cell injections improve outcomes in rat model of diabetic retinopathy
4